A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults
Clinical trial NCT05164094 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05164094
- Sponsor
- ModernaTX, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-28
- Primary completion
- 2026-10-05
- Enrollment
- 867
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.